Data / Form D filings / EnzymeBioSystems
EnzymeBioSystems: Form D filings
EnzymeBioSystems, a pharmaceuticals company in Las Vegas, NV, filed 2 Form D notices with the SEC in 2017. The latest, on October 24, 2017, reports $389,763 sold of a $3 million offering to 15 investors.
Find out what EnzymeBioSystems does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 8440 W. LAKE MEAD, SUITE 214, Las Vegas, NV, 89128
- Phone
- (702) 907-0615
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Nevada
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1471968
The full lists. Form D filings in Nevada: 610 rows, $30.50, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 24, 2017 | New notice | $3,000,000 | $389,763 | $2,610,237 | 15 | Sep 6, 2017 | sec.gov |
| Oct 24, 2017 | New notice | $3,000,000 | $389,763 | $2,610,237 | 15 | Sep 6, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Gary Rojewski | Executive Officer, Director | |
| John Dean Harper | Director |
Every Form D from the week of Oct 23, 2017 · All recent filings in Nevada · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what EnzymeBioSystems reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.